Finance

Lists
ALDX:NASDAQ
Aldeyra Therapeutics Inc
$1.51
0.00%
(0.00) 1D
$1.50
-0.58% (-0.0088)
After hours
Closed: Aug 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALDX...
Open
$1.53
High
$1.56
Low
$1.50
Mkt. cap
91.09M
Avg. vol.
1.38M
Volume
473.99K
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.38
Beta
1.21
Shares outstanding
60.33M
No. of employees
7
Open
$1.53
High
$1.56
Low
$1.50
Mkt. cap
91.09M
Avg. vol.
1.38M
Volume
473.99K
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.38
Beta
1.21
Shares outstanding
60.33M
No. of employees
7
News stories
From web sources and news partners
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees7
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitealdeyra.com
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Hold
Reiterated
$2.00
+32.5%
05/11/2026
Thomas Shrader
BTIG
Buy
Maintained
$9.00
+496%
03/17/2026
Clara Dong
Jefferies
Buy
Maintained
$7.00
+363.6%
10/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.43M
4.30M
2.41M
3.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.57M
2.36M
1.14M
2.37M
Operating expense
8.00M
6.67M
3.55M
5.85M
Total operating expenses
8.00M
6.67M
3.55M
5.85M
Operating income
-8.00M
-6.67M
-3.55M
-5.85M
Other non operating income
-
-
-
-
EBT including unusual items
-7.69M
-6.46M
-3.45M
-5.45M
EBT excluding unusual items
-7.69M
-6.46M
-3.45M
-5.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.69M
-6.46M
-3.45M
-5.45M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.10
-0.06
-0.09
Interest and investment income
788.69K
681.64K
562.98K
400.26K
Interest expense
-475.90K
-475.26K
-468.68K
-23.00
Net interest expenses
312.79K
206.38K
94.30K
400.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.94M
-6.60M
-3.48M
-5.78M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps